Impact of sorafenib on epidural fibrosis: An immunohistochemical study

AIM: To determine if sorafenib, an antineoplastic agent, could prevent the development of spinal epidural fibrosis (EF). METHODS: The study used CD105 and osteopontin antibodies in an immunohistochemical approach to quantify EF that occurred as a consequence of laminectomy in rats. Wistar albino rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanriverdi, Osman, Erdogan, Uzay, Tanik, Canan, Yilmaz, Ilhan, Gunaldi, Omur, Adilay, Huseyin Utku, Arslanhan, Ayca, Eseoglu, Metehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134279/
https://www.ncbi.nlm.nih.gov/pubmed/30211205
http://dx.doi.org/10.12998/wjcc.v6.i9.249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134279/
https://www.ncbi.nlm.nih.gov/pubmed/30211205
http://dx.doi.org/10.12998/wjcc.v6.i9.249

Ejemplares similares